OnCusp Therapeutics, Inc., headquartered in New York City, is a biopharmaceutical company dedicated to transforming cutting-edge preclinical innovation into clinically validated treatments for cancer patients worldwide. OnCusp was co-founded by Dr. Bing Yuan, Dr. Eric Slosberg, and Dr. Andy Fu, and has built a strong team of accomplished veterans with proven track records in building startup biotechs, leading successful preclinical and clinical programs, and creating value through global partnerships. The company is committed to accelerating the advancement of globally competitive oncology assets for patients.
Company Details
- Employees
- 22
- Founded
- -
- Address
- 433 Broadway, New York,new York 10013,united States
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.oncusptx.com
- Keywords
- Biotech, Pharmaceutical, Oncology.
- HQ
- New York, New York
Oncusp Therapeutics Questions
Oncusp Therapeutics's website is http://www.oncusptx.com
Oncusp Therapeutics's LinkedIn profile is https://www.linkedin.com/company/oncusp-therapeutics
Oncusp Therapeutics has
22 employees.
View email and phone details for 22
employees at Oncusp Therapeutics.
Oncusp Therapeutics's industry is
Pharmaceutical Manufacturing
Oncusp Therapeutics's top competitors are
Biospherix, Llc,
Nuvation Bio,
Kingdom Supercultures,
Immunic Therapeutics,
Delcath Systems,
Protara Therapeutics,
Transcend Therapeutics,
Royalty Pharma,
Aethon Therapeutics,
Lexeo Therapeutics.
Oncusp Therapeutics's categories are Pharmaceutical Manufacturing
Oncusp Therapeutics's founding year is 2021
